Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 59.15
-0.35 (-0.59%)
May 28, 2026, 11:09 AM HKT
Keymed Biosciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -522.64 | -515.24 | -359.36 | -308.12 | -3,887 |
Depreciation & Amortization | 95.61 | 91.84 | 68.78 | 35.79 | 20.94 |
Other Amortization | 2.41 | 1.39 | 0.39 | 0.34 | 0.08 |
Loss (Gain) From Sale of Assets | -0.03 | - | 0.07 | 0.39 | 0.71 |
Loss (Gain) From Sale of Investments | -30.26 | 1.02 | - | - | - |
Loss (Gain) on Equity Investments | 0.67 | 5.26 | 4.75 | 9.71 | 0.72 |
Stock-Based Compensation | 27.76 | 34.35 | 40.08 | 48.57 | 116.82 |
Other Operating Activities | -144.93 | -273.25 | -78.62 | -182.94 | 3,531 |
Change in Accounts Receivable | -38.61 | -35.76 | -27.09 | 3.98 | -3.98 |
Change in Inventory | -85.76 | -55.07 | -11.86 | -28.1 | -9.55 |
Change in Accounts Payable | 2.05 | -3.48 | 14.58 | 12.13 | -0.63 |
Change in Unearned Revenue | -35.53 | -0.45 | -0.81 | - | -7 |
Change in Income Taxes | -1.23 | -6.19 | -1.32 | - | - |
Change in Other Net Operating Assets | 18.06 | -34.04 | 46.8 | 6.32 | 23.99 |
Operating Cash Flow | -712.41 | -789.63 | -303.62 | -401.93 | -214.64 |
Capital Expenditures | -333.92 | -207.91 | -378.49 | -278.82 | -171.79 |
Sale of Property, Plant & Equipment | 1.87 | - | - | - | - |
Sale (Purchase) of Intangibles | -2.56 | -6.58 | -4.12 | -0.73 | -1.07 |
Investment in Securities | 265.71 | 162.4 | 700.46 | -575.02 | -1,870 |
Other Investing Activities | 107.98 | 119.8 | 150.35 | 208.98 | 6.95 |
Investing Cash Flow | 39.08 | 67.71 | 468.2 | -645.59 | -2,036 |
Long-Term Debt Issued | 654.09 | 468.79 | 360 | 89.95 | - |
Total Debt Issued | 654.09 | 468.79 | 360 | 89.95 | - |
Short-Term Debt Repaid | - | - | -0.23 | -0.33 | -41.82 |
Long-Term Debt Repaid | -632.91 | -135.55 | -93.66 | -14.52 | -12.91 |
Total Debt Repaid | -632.91 | -135.55 | -93.88 | -14.85 | -54.73 |
Net Debt Issued (Repaid) | 21.18 | 333.24 | 266.12 | 75.1 | -54.73 |
Issuance of Common Stock | 791.68 | - | - | - | 2,888 |
Repurchase of Common Stock | - | -32.43 | -32.9 | -51.14 | - |
Other Financing Activities | -24.14 | -16.91 | -161.09 | -32.03 | -8.5 |
Financing Cash Flow | 788.72 | 283.9 | 72.13 | -8.06 | 3,638 |
Foreign Exchange Rate Adjustments | -30.46 | 5.41 | 10.25 | 139.03 | -66.65 |
Net Cash Flow | 84.93 | -432.62 | 246.96 | -916.55 | 1,321 |
Free Cash Flow | -1,046 | -997.55 | -682.11 | -680.76 | -386.42 |
Free Cash Flow Margin | -146.07% | -233.00% | -192.63% | -680.33% | -350.44% |
Free Cash Flow Per Share | -3.82 | -3.81 | -2.61 | -2.61 | -2.40 |
Cash Interest Paid | 15.8 | 18.15 | 10.49 | 1.85 | - |
Levered Free Cash Flow | -749.94 | -565.77 | -714.05 | -410.26 | -231.71 |
Unlevered Free Cash Flow | -739.37 | -554.23 | -703.27 | -405.01 | -224.75 |
Change in Working Capital | -141.01 | -134.99 | 20.29 | -5.67 | 2.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.